Search Results - Vidula Dixit

  • Showing 1 - 1 results of 1
Refine Results
  1. 1

    Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically-controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy. by Deborah Charych, Samira Khalili, Vidula Dixit, Peter Kirk, Thomas Chang, John Langowski, Werner Rubas, Stephen K Doberstein, Michael Eldon, Ute Hoch, Jonathan Zalevsky

    Published in PLoS ONE (2017-01-01)
    Get full text
    Article


Search Tools: